MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Impact of Cognition on Social Engagement in Community-based Older Adults with Parkinsonism

    M. Roy, Md, D. Gonzalez, Phd, M. Tosin, Phd, C. Goetz, Md, R. Wilson, Phd (Chicago, USA)

    Objective: To investigate how cognition and gait influence social engagement in parkinsonism. Background: Social engagement is vital to quality of life in parkinsonism, yet the…
  • 2025 International Congress

    Dose Optimization of Foslevodopa/Foscarbidopa: Post Hoc Analysis of Study Completers

    J. Aldred, M. Bouchard, D. Kern, P. Mir, L. Bergmann, R. Gupta, M. O'Meara, J. Samuelsson, B. Bergmans (Spokane, USA)

    Objective: To describe dose optimization, efficacy, and safety of foslevodopa/foscarbidopa (LDp/CDp) in patients with advanced Parkinson’s disease (PwaPD) who completed a 52-week open-label study. Background:…
  • 2025 International Congress

    Prospective observational study on the effects of physical exercise and lifestyle modifications in patients with Parkinson’s disease

    T. Lata (Mumbai, India)

    Objective: This study aimed to assess the effectiveness of physical activity, which includes all movements that increase energy expenditure, in conjunction with exercise, characterized as…
  • 2025 International Congress

    G-Can, the GBA1 Canada Initiative

    L. Chebon, P. Halder, E. Fon, T. Durcan, M. Parent, N. Dupre, M. Sharp, R. Postuma, G. Armstrong, A. Milnerwood, A. Dagher, J. Raamsdonk, J. Trempe, T. Goldsmith, X. Chen, N. Aprahamian, Z. You, M. Nicoleau, E. Deneault, A. Bayne, C. Laflamme, P. Mcpherson, M. Pandolfo, G. Rouleau, Z. Gan-Or (Québec, Canada)

    Objective: G-Can, the GBA1 Canada Initiative, is an open-science platform which aims to advance GBA1 research and develop treatments for GBA1 mutation-related Parkinson's disease (PD).…
  • 2025 International Congress

    Parkinson’s Disease Dogs to assist Gait Impairment: A Pilot study of Patient Experience and Outcomes

    A. Gallagher, C. O'Keeffe, J. Inocentes, J. Liegey, J. Dowler, C. Fearon, T. Lynch (Dublin, Ireland)

    Objective: This pilot study was designed to evaluate Parkinson's disease assistance dogs as a novel non-pharmacological therapy for gait impairment in Parkinson's disease Background: Gait…
  • 2025 International Congress

    A Novel Therapeutic Targeting the tPA-NMDAr Interaction for Parkinson’s Disease

    M. Blanc, E. Su, D. Torrente, B. Zhang, D. Vivien, F. Lesept, N. Deletage (Lyon & Caen, France)

    Objective: Glunomab, a monoclonal antibody designed to inhibit the interaction between tissue plasminogen activator (tPA) and the N-methyl-D-aspartate receptor (NMDAr), has demonstrated therapeutic potential across…
  • 2025 International Congress

    Impact of ND0612 on Levodopa-Induced Dyskinesia in Parkinson’s Disease: Post hoc Analyses From a Randomized, Active-Controlled Study

    A. Ellenbogen, R. Pahwa, J. Hernández-Vara, N. Lopes, J. Pereira, A. Espay (Farmington Hills, USA)

    Objective: To evaluate dyskinesia-related outcomes between optimized subcutaneously administered levodopa/carbidopa (ND0612) + immediate-release levodopa/carbidopa (IR-LD/CD) vs optimized oral IR-LD/CD in patients with Parkinson’s disease (PD).…
  • 2025 International Congress

    “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.

    A. Sawal, A. Kumar, A. Singh, K. Alreja, S. Tomar, A. Tiwari (chandigarh, India)

    Objective: To devise a portable skid free mat bearing a combination of patterned and pictographic visual cues for freezing of gait. Background: Freezing of gait…
  • 2025 International Congress

    Incidence and Determinants of Nodule formation in continuous subcutaneous Foslevodopa/Foscarbidopa Infusion therapy.

    S. Bray, D. Tsui, M. Georgiades, X. Chen, D. Galea, H. Morales Briceno, V. Fung (Westmead, Australia)

    Objective: This study aims to evaluate the incidence of subcutaneous (SC) nodules in Parkinson’s patients treated with continuous 24-hour SC infusion of foslevodopa/foscarbidopa (LDp/CDp) and…
  • 2025 International Congress

    Longitudinal Remote Monitoring with Wearable Technology in Parkinson Disease: Initiation of A Dyskinesia Insight Network Observational Study

    R. Gilron, A. Hare, M. Grall, P. Qin, S. Isaacson (San Francsico, USA)

    Objective: Evaluate the utility of wearable digital health technology for identifying and characterizing levodopa-induced dyskinesia in real-world settings. Background: Patients with Parkinson disease (PwP) frequently…
  • « Previous Page
  • 1
  • …
  • 140
  • 141
  • 142
  • 143
  • 144
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley